KDM2B and cancer: Moreover, EZH2, along with the potential epigenetic regulator lysine-specific demethylase 2B (KDM2B), dampens colorectal cancer migration, invasion, and maintenance of cancer stem cells via the PI3K/AKT pathway [42].